InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Gollob Jared, Directeur Médical. Insider active across 2 companies, notably Kymera Therapeutics, Inc.. Cumulatively, 13 disclosures have been recorded. Activity tracked since 1 November 2021. The latest transaction was disclosed on 2 March 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Gollob Jared
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
17,650 股0Common StockSEC:0001193125-26-091983:0
49,307 股@ US$5.3354.3% 占其流量Common StockSEC:0001193125-25-311503:0
28,999 股@ US$1.3117.2% 占其流量Common StockSEC:0001193125-25-240430:0
800 股@ US$1.310.5% 占其流量Common StockSEC:0001193125-25-239144:0
30,000 股0Common StockSEC:0000950170-25-031144:0
16,455 股@ US$2.0820.1% 占其流量Common StockSEC:0000950170-24-084003:0
24,375 股0Common StockSEC:0000950170-24-025101:0
400 股@ US$2.080.5% 占其流量Common StockSEC:0000950170-24-023168:0
46,137 股@ US$2.0856.9% 占其流量Common StockSEC:0000950170-24-013482:0
18,750 股0Common StockSEC:0000899243-23-006981:0
10,208 股@ US$1.313.0% 占其流量Common StockSEC:0000899243-22-016538:0
12,600 股0Common StockSEC:0000899243-22-009076:0
20,000 股@ US$1.315.5% 占其流量Common StockSEC:0000899243-21-042437:0
13 条申报中的 13 条
About Gollob Jared
Gollob Jared is Chief Medical Officer at Kymera Therapeutics, Inc. The 13 filings on record, with sampled data from 2021-11-02 to 2026-03-04, are described as option exercises. The buy and sell volumes shown for this sample are EUR 0 and EUR 0.
